A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223

被引：0
|
作者：
Viviana Frantellizzi
Fabio Monari
Manlio Mascia
Renato Costa
Giuseppe Rubini
Angela Spanu
Alessio Farcomeni
Elisa Lodi Rizzini
Luca Cindolo
Alessandra Murabito
Valentina Lavelli
Susanna Nuvoli
Laura Cosma
Valeria Dionisi
Anna Giulia Nappi
Marco Andreola
Giuseppe De Vincentis
机构：
[1] “Sapienza” University of Rome,Department of Molecular Medicine Sapienza
[2] S.Orsola-Malpighi Hospital,Radiation Oncology Center
[3] “Spirito Santo” Hospital,Unit of Nuclear Medicine
[4] University of Palermo,Unit of Nuclear Medicine, Biomedical Department of Internal and Specialist Medicine
[5] University of Bari “Aldo Moro”,Nuclear Medicine Department
[6] University of Sassari,Unit of Nuclear Medicine, Department of Medical Surgical and Experimental Sciences
[7] University of Rome “Tor Vergata”,Department of Economics & Finance
[8] S.Orsola-Malpighi Hospital,Nuclear Medicine Unit
[9] “Villa Stuart” Private Hospital,Department of Urology
[10] “Sapienza” University of Rome,Department of Radiological Sciences, Oncology and Anatomical Pathology Sapienza
来源：
Aging Clinical and Experimental Research | 2021年 / 33卷
关键词：
mCRPC; Elderly; Overall survival; Radium-223; Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：651 / 658
页数：7
相关论文
共 50 条
  • [1] A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223
    Frantellizzi, Viviana
    Monari, Fabio
    Mascia, Manlio
    Costa, Renato
    Rubini, Giuseppe
    Spanu, Angela
    Farcomeni, Alessio
    Rizzini, Elisa Lodi
    Cindolo, Luca
    Murabito, Alessandra
    Lavelli, Valentina
    Nuvoli, Susanna
    Cosma, Laura
    Dionisi, Valeria
    Nappi, Anna Giulia
    Andreola, Marco
    De Vincentis, Giuseppe
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (03) : 651 - 658
  • [2] Radium-223 for Metastatic Castrate-Resistant Prostate Cancer
    Sindhu, Kunal K.
    Nehlsen, Anthony D.
    Stock, Richard G.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2022, 12 (04) : 312 - 316
  • [3] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [4] Radium-223 therapy for metastatic castrate-resistant prostate cancer
    Lehman, Ashley
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [5] Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
    Modi, Dipenkumar
    Hwang, Clara
    Mamdani, Hirva
    Kim, Seongho
    Gayar, Hesham
    Vaishampayan, Ulka
    Joyrich, Richard
    Heath, Elisabeth I.
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 373 - 380
  • [6] INFLUENCE OF PALLIATIVE RADIOTHERAPY ON TOXICITY AND SURVIVAL IN PATIENTS TREATED WITH RADIUM-223 DICHLORIDE FOR METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
    Charrois-Durand, Cedric
    Delouya, Guila
    Taussky, Daniel
    Barkati, Maroie
    Saad, Fred
    Lattouf, Jean-Baptiste
    Perrotte, Paul
    Karakiewicz, Pierre
    Soulieres, Denis
    Blais, Normand
    Hamilou, Zineb
    Juneau, Daniel
    Plouznikoff, Nicolas
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S72 - S73
  • [7] Overall survival in elderly mCRPC patients treated with Radium-223: a national multicenter study
    Lavelli, V.
    Cosma, L.
    Monari, F.
    Mascia, M.
    Costa, R.
    Rubini, G.
    Spanu, A.
    Farcomeni, A.
    Rizzini, E. Lodi
    Cindolo, L.
    Murabito, A.
    Nuvoli, S.
    Frantellizzi, V.
    Dionisi, V.
    Nappi, A.
    De Vincentis, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S423 - S423
  • [8] Pain Response to Radium-223 in Men With Metastatic Castrate-Resistant Prostate Cancer
    Zhang, I.
    Gilbo, P.
    Cox, B. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E530 - E530
  • [9] The National Radium-223 Dichloride Audit Group: Data from Patients in 17 UK Oncology Centres with Metastatic Castrate-resistant Prostate Cancer Treated with Radium-223 Dichloride
    Randhawa, M.
    Jones, R.
    Stratton, I.
    Bahl, A.
    Bottomley, D.
    Carruthers, H.
    [J]. CLINICAL ONCOLOGY, 2019, 31 (02) : E24 - E24
  • [10] Clinical response to radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
    Zhang, Isabella
    Gilbo, Philip
    Kohn, Nina
    Cox, Brett
    [J]. PRACTICAL RADIATION ONCOLOGY, 2018, 8 (06) : 452 - 457
12345